|
Atomistry » Chlorine » PDB 7sqe-7t2x » 7szq | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Chlorine » PDB 7sqe-7t2x » 7szq » |
Chlorine in PDB 7szq: Human P300 Complexed with An Azaindazole InhibitorEnzymatic activity of Human P300 Complexed with An Azaindazole Inhibitor
All present enzymatic activity of Human P300 Complexed with An Azaindazole Inhibitor:
2.3.1.48; Protein crystallography data
The structure of Human P300 Complexed with An Azaindazole Inhibitor, PDB code: 7szq
was solved by
L.M.Shewchuk,
R.A.Reid,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Human P300 Complexed with An Azaindazole Inhibitor
(pdb code 7szq). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Human P300 Complexed with An Azaindazole Inhibitor, PDB code: 7szq: Chlorine binding site 1 out of 1 in 7szqGo back to![]() ![]()
Chlorine binding site 1 out
of 1 in the Human P300 Complexed with An Azaindazole Inhibitor
![]() Mono view ![]() Stereo pair view
Reference:
X.Tian,
D.Suarez,
D.Thomson,
W.Li,
E.A.King,
L.Lafrance,
J.Boehm,
L.Barton,
C.Di Marco,
C.Martyr,
R.Thalji,
J.Medina,
S.Knight,
D.Heerding,
E.Gao,
E.Nartey,
T.Cecconie,
C.Nixon,
G.Zhang,
T.J.Berrodin,
C.Phelps,
A.Patel,
X.Bai,
K.Lind,
N.Prabhu,
J.Messer,
Z.Zhu,
L.Shewchuk,
R.Reid,
A.P.Graves,
C.Mchugh,
B.Mangatt.
Discovery of Proline-Based P300/Cbp Inhibitors Using Dna-Encoded Library Technology in Combination with High-Throughput Screening. J.Med.Chem. V. 65 14391 2022.
Page generated: Sun Jul 13 07:16:16 2025
ISSN: ISSN 0022-2623 PubMed: 36302181 DOI: 10.1021/ACS.JMEDCHEM.2C00670 |
Last articlesFe in 2G6MFe in 2G6L Fe in 2G6K Fe in 2FYN Fe in 2G6J Fe in 2G6I Fe in 2G6H Fe in 2G5G Fe in 2G3H Fe in 2G36 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |